Vitro, a global developer, manufacturer and marketer of integral diagnostics solutions and data integration in Cancer Diagnostics, today announced that it has appointed Biocare Medical, a global ...
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...
BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, today announces it was named a Fierce Life Sciences Innovation Awards winner by Fierce ...
1don MSN
A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma-the most common type of malignant brain ...
Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...
Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...
News-Medical.Net on MSN16h
New technique effectively identifies aggressive medulloblastomaCanadian researchers have developed an effective new technique for identifying aggressive medulloblastoma-the most common type of malignant brain tumour in children-and potentially sparing young ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback